{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:20:55Z","timestamp":1789719655946,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10072-019-03830-6","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T12:02:57Z","timestamp":1553256177000},"page":"1383-1391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6543-0568","authenticated-orcid":false,"given":"Pasquale","family":"Annunziata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"D\u2019amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Laroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Mancardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vitetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"key":"3830_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.autrev.2011.05.018","volume":"11","author":"AT Borchers","year":"2012","unstructured":"Borchers AT, Gershwin ME (2012) Transverse myelitis. Autoimmun Rev 11:231\u2013248","journal-title":"Autoimmun Rev"},{"key":"3830_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1212\/WNL.59.4.499","volume":"59","author":"Transverse Myelitis Consortium Working Group","year":"2002","unstructured":"Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499\u2013505","journal-title":"Neurology"},{"key":"3830_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ana.410040110","volume":"4","author":"AH Ropper","year":"1978","unstructured":"Ropper AH, Poskanzer DC (1978) The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 4:51\u201359","journal-title":"Ann Neurol"},{"key":"3830_CR4","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1212\/WNL.31.8.966","volume":"31","author":"M Berman","year":"1981","unstructured":"Berman M, Feldman S, Alter M, Zilber N, Kahana E (1981) Acute transverse myelitis: incidence and etiologic considerations. Neurology 31:966\u2013971","journal-title":"Neurology"},{"key":"3830_CR5","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1001\/archneur.1993.00540050074019","volume":"50","author":"DR Jeffery","year":"1993","unstructured":"Jeffery DR, Mandler RN, Davis LE (1993) Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 50:532\u2013535","journal-title":"Arch Neurol"},{"key":"3830_CR6","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"3830_CR7","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/archneurol.2010.107","volume":"67","author":"A Gajofatto","year":"2010","unstructured":"Gajofatto A, Monaco S, Fiorini M et al (2010) Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. Arch Neurol 67:724\u2013730","journal-title":"Arch Neurol"},{"key":"3830_CR8","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1177\/1352458517731911","volume":"24","author":"M Gastaldi","year":"2018","unstructured":"Gastaldi M, Marchioni E, Banfi P, Mariani V, di Lodovico L, Bergamaschi R, Alfonsi E, Borrelli P, Ferraro OE, Zardini E, Pichiecchio A, Cortese A, Waters P, Woodhall M, Ceroni M, Mauri M, Franciotta D (2018) Predictors of outcome in a large retrospective cohort of patients with transverse myelitis. Mult Scler 24:1743\u20131752","journal-title":"Mult Scler"},{"key":"3830_CR9","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1212\/01.wnl.0000188896.48308.26","volume":"65","author":"J Seze De","year":"2005","unstructured":"De Seze J, Lanctin C, Lebrun C et al (2005) Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 65:1950\u20131953","journal-title":"Neurology"},{"key":"3830_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1191\/135248506ms1260oa","volume":"12","author":"J Bruna","year":"2006","unstructured":"Bruna J, Mart\u00ednez-Y\u00e9lamos S, Mart\u00ednez-Y\u00e9lamos A, Rubio F, Arbizu T (2006) Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler 12:169\u2013173","journal-title":"Mult Scler"},{"key":"3830_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/archneur.1963.00460080021002","volume":"9","author":"PH Altrocchi","year":"1963","unstructured":"Altrocchi PH (1963) Acute transverse myelopathy. Arch Neurol 9:111\u2013119","journal-title":"Arch Neurol"},{"key":"3830_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/archneur.1973.00490220060009","volume":"28","author":"HL Lipton","year":"1973","unstructured":"Lipton HL, Teasdall RD (1973) Acute transverse myelopathy in adults. A follow-up study. Arch Neurol 28:252\u2013257","journal-title":"Arch Neurol"},{"key":"3830_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1600-0404.1990.tb00990.x","volume":"81","author":"PB Christensen","year":"1990","unstructured":"Christensen PB, Wermuth L, Hinge HH, B\u00f8mers K (1990) Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 81:431\u2013435","journal-title":"Acta Neurol Scand"},{"key":"3830_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0022-510X(95)00353-4","volume":"138","author":"UK Misra","year":"1996","unstructured":"Misra UK, Kalita J, Kumar S (1996) A clinical, MRI and neurophysiological study of acute transverse myelitis. J Neurol Sci 138:150\u2013156","journal-title":"J Neurol Sci"},{"key":"3830_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG, International Panel for NMO Diagnosis (2015) International diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"3830_CR16","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","volume":"54","author":"B Farrell","year":"1991","unstructured":"Farrell B, Godwin J, Richards S, Warlow C (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54:1044\u20131054","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3830_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1600-0404.2007.00835.x","volume":"115","author":"TF Scott","year":"2007","unstructured":"Scott TF (2007) Nosology of idiopathic transverse myelitis syndromes. Acta Neurol Scand 115:371\u2013376","journal-title":"Acta Neurol Scand"},{"key":"3830_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.410260508","volume":"26","author":"DH Miller","year":"1989","unstructured":"Miller DH, Ormerod IE, Rudge P, Kendall BE, Moseley IF, McDonald WI (1989) The early risk ofmultiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 26:635\u2013639","journal-title":"Ann Neurol"},{"key":"3830_CR19","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/brain\/124.8.1509","volume":"124","author":"J Seze De","year":"2001","unstructured":"De Seze J, Stojkovic T, Breteau G et al (2001) Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases. Brain 124:1509\u20131521","journal-title":"Brain"},{"key":"3830_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jns.2003.10.009","volume":"217","author":"M Harzeim","year":"2004","unstructured":"Harzeim M, Schlegel U, Urbach H, Klockgether T, Schmidt S (2004) Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci 217:217\u2013223","journal-title":"J Neurol Sci"},{"key":"3830_CR21","first-page":"115","volume":"16","author":"A Campi","year":"1995","unstructured":"Campi A, Filippi M, Comi G (1995) Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. Am J Neuroradiol 16:115\u2013123","journal-title":"Am J Neuroradiol"},{"key":"3830_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0404.1989.tb03909.x","volume":"80","author":"J Marti-Fabregas","year":"1989","unstructured":"Marti-Fabregas J, Martinez JM, Illa I, Escartin A (1989) Myelopathy of unknown origin. Acta Neurol Scand 80:455\u2013460","journal-title":"Acta Neurol Scand"},{"key":"3830_CR23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.20770","volume":"59","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566\u2013569","journal-title":"Ann Neurol"},{"key":"3830_CR24","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/archneur.63.10.1398","volume":"63","author":"TF Scott","year":"2006","unstructured":"Scott TF, Kassab S, Pittock SJ (2006) Neuromyelitis optica antibodies and acute partial transverse myelitis. Arch Neurol 63:1398\u20131400","journal-title":"Arch Neurol"},{"key":"3830_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1468-1331.1998.510035.x","volume":"5","author":"R Bakshi","year":"1998","unstructured":"Bakshi R, Kinkel PR, Mechtler LL, Bates VE, Lindsay BD, Esposito SE, Kinkel WR (1998) Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patient with and without multiple sclerosis. Eur J Neurol 5:35\u201348","journal-title":"Eur J Neurol"},{"key":"3830_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2377-13-135","volume":"13","author":"A Cobo Calvo","year":"2013","unstructured":"Cobo Calvo A, Ma\u00f1\u00e9 Mart\u00ednez MA, Alentorn-Palau A, Bruna Escuer J, Romero Pinel L, Mart\u00ednez-Y\u00e9lamos S (2013) Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series. BMC Neurol 13:135","journal-title":"BMC Neurol"},{"key":"3830_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1212\/WNL.41.5.703","volume":"41","author":"DS Tippett","year":"1991","unstructured":"Tippett DS, Fishman PS, Panitch HS (1991) Relapsing transverse myelitis. Neurology 41:703\u2013706","journal-title":"Neurology"},{"key":"3830_CR28","first-page":"1290","volume":"60","author":"KK Kim","year":"2003","unstructured":"Kim KK (2003) Idiopathic recurrent transverse myelitis. Arch Neurol 60:1290\u20131294","journal-title":"Arch Neurol"},{"key":"3830_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1212\/01.WNL.0000101715.32569.1A","volume":"62","author":"LK Hummers","year":"2004","unstructured":"Hummers LK, Krishnan C, Casciola-Rosen L, Rosen A, Morris S, Mahoney JA, Kerr DA, Wigley FM (2004) Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 62:147\u2013149","journal-title":"Neurology"},{"key":"3830_CR30","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0140-6736(99)04745-5","volume":"355","author":"DN Irani","year":"2000","unstructured":"Irani DN, Kerr DA (2000) 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 355:901","journal-title":"Lancet"},{"key":"3830_CR31","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s004150200074","volume":"249","author":"J Seze De","year":"2002","unstructured":"De Seze J, Peoc\u2019h K, Ferriby D, Stojkovic T, Laplanche JL, Vermersch P (2002) 14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis. J Neurol 249:626\u2013627","journal-title":"J Neurol"},{"key":"3830_CR32","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1177\/1352458509345906","volume":"15","author":"J Young","year":"2009","unstructured":"Young J, Quinn S, Hurrell M, Taylor B (2009) Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler 15:1295\u20131302","journal-title":"Mult Scler"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03830-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-03830-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03830-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:22:53Z","timestamp":1584750173000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-03830-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3830"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-03830-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]},"assertion":[{"value":"11 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All study documents and procedures were approved by the Ethic Committee of the Medical School of the University of Siena and the local ethics boards of the other participating centers. All patients gave their informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"G.M., C.C., M.G., E.M., and F.V.declare no financial or other conflicts of interest. P.A. received financial support from Novartis, Biogen, and Almirall for research and attending meetings. G.L.M. received financial support from Biogen Idec, Merck Serono, Novartis, Teva, Genzyme, and Sanofi Aventis for lecturing, travel expenses, attending meetings, and research. A.L. received financial support for travel and attending meeting from Merck, Sanofi Genzyme, Teva, Biogen and Novartis. E.D\u2019A. reports personal fees from Teva, Merck Serono, Biogen, Bayer, and Novartis. F.P. received personal compensation for advisory board and speaking activities from Almirall, Biogen, Cilgane, Merck, Novartis, Roche, Sanofi, and Teva. P.S. has received speaker and advisory boards honoraria and travel grants from TEVA, Merck Serono, Sanofi-Genzyme, Novartis, and Biogen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}